Research interest focuses on its interaction with multiple hormonal systems simultaneously, supporting advanced experimental models designed to explore integrated metabolic regulation
Once released, GLP-1 enhances insulin secretion from pancreatic beta cells (in a glucose-dependent manner) and improves postprandial glucose control while suppressing glucagon release to prevent unnecessary glucose production
Microdosing GLP-1 for Weight Loss and Beyond
This is why transparency around pharmacy oversight, preparation standards, and testing matters
NAD+ supports the mitochondrial machinery that converts available fuel into usable energy
Associating GLP- 1 or glucagon receptor agonists with core hormones like estrogens, thyroid hormones, and dexamethasone was the strategy employed (reviewed in [137, 138])